Radio and PodcastLive Radio & Podcasts
Science & Medicine
Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech
Synopsis: This episode is proudly sponsored by Quartzy. Roivant Sciences CEO Matt Gline returns to Biotech 2050 for a deeply reflective conversation with host Rahul Chaturvedi on what it really takes to build a biotech c...
About This Episode
Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech is an episode from Biotech 2050 Podcast by Biotech2050 Podcast. Synopsis: This episode is proudly sponsored by Quartzy. Roivant Sciences CEO...
Podcast
This episode belongs to Biotech 2050 Podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Dec 17, 2025, 00:34:25 long, audio available.
Related Episodes
Continue listening to more episodes from Biotech 2050 Podcast.
Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients
Jun 10, 2026 - 00:41:21
Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
May 13, 2026 - 00:33:34
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Apr 16, 2026 - 00:23:07
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Mar 6, 2026 - 00:14:16
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Feb 11, 2026 - 00:25:06
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Feb 10, 2026 - 00:26:40